Zecevic, L., Mekic, M., Subasic, D., Hadziabulic, M., Isak, E., Subasic, E., & Selmanovic, K. (2019). Expression of NK (CD16+56+) and B cells (CD19) Receptor Molecules as a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment. Med Arch.

Zecevic, Lamija, Mevludin Mekic, Djemo Subasic, Majda Hadziabulic, Edmira Isak, Emina Subasic, und Kenan Selmanovic. "Expression of NK (CD16+56+) and B Cells (CD19) Receptor Molecules As a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment." Med Arch 2019.

Zecevic, Lamija, et al. "Expression of NK (CD16+56+) and B Cells (CD19) Receptor Molecules As a Reliable Clinical Response Biomarkers of SLE and RA Patients Under the Rituximab Treatment." Med Arch 2019.